Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Alaw Therapeutics Announces Two Major Pipeline Milestones Advancing Brain-Penetrant CDK Oncology Programs
Saturday, May 30, 2026Alaw Therapeutics Inc Alaw a clinicalstage biotechnology company developing precision oncology therapeutics designed to control oncogenic proliferation tumor survival and therapeutic resistance
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
Friday, May 29, 2026AstraZenecas IMFINZI durvalumab in combination with Bacillus CalmetteGurin BCG induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCGnave highrisk nonmuscleinvasive bladder cancer NMIBC
Adcendo ApS Announces Clinical Collaboration and Supply Agreement with MSD to Evaluate ADCE-T02 in Combination with KEYTRUDA® (Pembrolizumab) in a Phase Ib Study in Patients with Advanced Solid Tumors
Wednesday, May 27, 2026Adcendo ApS Adcendo a biotech company focused on the development of first and bestinclass antibodydrug conjugates ADCs for the treatment of cancers with high unmet medical need today announced that it has entered
ProBioGen Launches AGE1.CR.ReX Designer Cell Line for High-Titer Poxvirus Production
Wednesday, May 27, 2026ProBioGen today announced the launch of AGECRReX its nextgeneration avian designer cell line for stable hightiter poxvirus production and rapid generation of recombinant modified vaccinia Ankara MVA
Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine
Tuesday, May 26, 2026H Lundbeck AS Lundbeck today announced that the Ministry of Food and Drug Safety MFDS of South Korea has granted marketing authorization for eptinezumab for use in adults with migraine
Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery
Thursday, May 21, 2026Incyte and Genesis Molecular AI today announced a significant expansion of their strategic collaboration building and deploying stateoftheart AI to accelerate the discovery of novel molecules for collaboration targets selected by Incyte
Hansa Biopharma enters into €115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA
Tuesday, May 19, 2026Hansa Biopharma AB and SERB SA SERB today announced an exclusive licensing agreement for development and commercialization of IDEFIRIX imlifidase in the European Union EU United Kingdom UK
Parexel Launches ParexelAI™, Delivering AI Innovation to Accelerate Clinical Development
Tuesday, May 19, 2026Parexel a leading global clinical development partner providing insightsdriven Clinical and Consulting solutions to the worlds life sciences industry today introduced ParexelAI an innovative proprietary suite of humanled AI services
Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
Tuesday, May 19, 2026Sino Biological Inc a global leader in recombinant technology is proud to announce the launch of its innovative XPressMAX CellFree Protein Synthesis Kit Cat CFKIT a cuttingedge solution designed
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
Monday, May 18, 2026Boehringer Ingelheim today announced that Japans Ministry of Health Labour and Welfare MHLW has approved JASCAYD nerandomilast for the treatment of adults with idiopathic pulmonary fibrosis IPF
